Radiopharmaceuticals for the Royal Marsden come from GE Healthcare
- The Royal Marsden NHS Foundation Trust
- London
- Direct
- 2 March 2026 to 1 March 2028
The Royal Marsden NHS Foundation Trust buys radiopharmaceuticals for clinical use from GE Healthcare. The supply covers medical isotopes and related diagnostic agents for the trust's oncology and nuclear medicine services.
The trust awarded the £120,000 contract directly in February 2026, without a tender. The two-year deal runs to March 2028.
Contract ends March 2028
- What
- Radiopharmaceuticals and contrast media
- Supplier
- GE Healthcare
- Value
- £120,000
- How it was bought
- Direct
- Dates and next
- Mar 2026 to Mar 2028